Clinical Trial Update: Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial assessed the safety and efficacy of fluocinolone acetonide intravitreal implants in patients with noninfectious posterior uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noninfectious Posterior Uveitis

Drugs mentioned

• Retisert (fluocinolone acetonide)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Noninfectious Posterior Uveitis | Phase 2, Phase 3 | Status: COMPLETED